Fluciclovine Positron Emission Tomography

Fluciclovine-PET Uptake in Microcystic Meningioma Mimicking High-grade Glioma: A Case Report
Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0
Diagnostic accuracy of anti-3-[<sup>18</sup>F]-FACBC PET/MRI in gliomas
(18)F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study
Distinguishing Progression from Pseudoprogression in Glioblastoma Using (18)F-Fluciclovine PET
Diagnostic Value of 18 F-FACBC PET/MRI in Brain Metastases
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group

Focal 18F-fluciclovine avid intracranial lesions incidentally detected in patients undergoing PET/CT imaging for prostate cancer are most often CNS asymptomatic meningiomas ¹⁾

¹⁾

Baiomy A, Schellingerhout D, Chapin BF, Weinberg JS, Raza SM, Macapinlac H, Ravizzini G. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer. Nucl Med Commun. 2021 Mar 12. doi: 10.1097/MNM.0000000000001389. Epub ahead of print. PMID: 33741867.